ExAdEx-Innov
Created in 2022
Up & running (A)
Existing signals show a regular activitySocial networks
2,600Activities
Technologies
Entity types
Location
27 Rue du Professeur Delvalle, 06000 Nice, France
Nice
France
Employees
Scale: 2-10
Estimated: 7
SIREN
918581133Engaged catalyst
23
0 0Added in Motherbase
1 year, 7 months ago
Value proposition
Reducing the gap between Lab and Clinical Trials with Physiological and Pathological Non-Animal Models
Unique R&D platform of donor-derived real human adipose tissue ex vivo models for pharmaceutical drug development (obesity, chronic metabolic diseases), dermo-cosmetic, nutraceutical, aesthetic and reconstructive surgery research.
ExAdEx-Innov owns exclusive worldwide rights to ExAdEx patented breakthrough technology to develop preclinical models derived from human adipose tissue obtained from patients. These models maintain their native 3D structure, stem cells, functionality, and vascularization over the long term in culture, providing a faithful representation of clinical conditions. They enable the pharmaceutical industry to generate reliable human data in the laboratory, significantly reducing clinical failure rates and allowing for treatments better tailored to target patient profiles. More ethical, faster, and clinically relevant than animal testing, these models de-risk the evaluation of the efficacy and safety of treatments targeting obesity, metabolic diseases, and dermatological conditions.
ExAdEx Technology has been develop in French academic laboratories of excellence (Côte d’Azur University, Institut de Biologie Valrose, CNRS, INSERM, University Hospital of Nice) and is supported by SATT Sud-Est, IdEX Université Côte d'Azur, CNRS Innovation, Provence Côte d'Azur Business Incubator, Métropôle Nice Côte d’Azur and Eurobiomed Healthtech Accelerator.
ExAdEx-Innov is member of Eurobiomed and Cosmetic Valley clusters and of Les DeepTech community by BpiFrance.
adipose tissue, cosmetic testing, research platform, in vitro, ex vivo, models, obesity, metabolic diseases, pharmaceutical testing, microphysiological, preclinical, drug development, energy expenditure, 3D models, MPS, organoids, NAMs, Alternatives to animal testing, vascular model, fibrosis, inflammation, physio-pathology, dermo-cosmetics, aesthetic medicine, and fat tissueOriginal language
Reducing the gap between Lab and Clinical Trials with Physiological and Pathological Non-Animal Models
Unique R&D platform of donor-derived real human adipose tissue ex vivo models for pharmaceutical drug development (obesity, chronic metabolic diseases), dermo-cosmetic, nutraceutical, aesthetic and reconstructive surgery research.
ExAdEx-Innov owns exclusive worldwide rights to ExAdEx patented breakthrough technology to develop preclinical models derived from human adipose tissue obtained from patients. These models maintain their native 3D structure, stem cells, functionality, and vascularization over the long term in culture, providing a faithful representation of clinical conditions. They enable the pharmaceutical industry to generate reliable human data in the laboratory, significantly reducing clinical failure rates and allowing for treatments better tailored to target patient profiles. More ethical, faster, and clinically relevant than animal testing, these models de-risk the evaluation of the efficacy and safety of treatments targeting obesity, metabolic diseases, and dermatological conditions.
ExAdEx Technology has been develop in French academic laboratories of excellence (Côte d’Azur University, Institut de Biologie Valrose, CNRS, INSERM, University Hospital of Nice) and is supported by SATT Sud-Est, IdEX Université Côte d'Azur, CNRS Innovation, Provence Côte d'Azur Business Incubator, Métropôle Nice Côte d’Azur and Eurobiomed Healthtech Accelerator.
ExAdEx-Innov is member of Eurobiomed and Cosmetic Valley clusters and of Les DeepTech community by BpiFrance.
Home - ExAdEx-Innov: Real Human Fat Ex vivo
Transforming drug development and product testing with ethical, sustainable and human-relevant models of Real Human Fat Ex vivo
https://exadex-innov.com/
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
 L'Oréal Cosmetics, Personal Care Product Manufacturing | L'Oréal Cosmetics, Personal Care Product Manufacturing | Other 17 Jul 2025 | | |
 LE CAMP Startup accelerator & VC, IT Services and IT Consulting | LE CAMP Startup accelerator & VC, IT Services and IT Consulting | Other 31 Mar 2025 | | |
 | Telecom Valley | Other 4 Apr 2025 | | |
 Le Journal des Entreprises Media, Newspaper Publishing | Le Journal des Entreprises Media, Newspaper Publishing | Other 4 Apr 2025 | | |
 La Tribune Media, Newspapers | La Tribune Media, Newspapers | Other 9 Oct 2024 | | |
 Innov'Alliance - Competitiveness Cluster for Naturalness and Plant-Based Industries Public business cluster, French Cluster, Food and Beverage Manufacturing | Innov'Alliance - Competitiveness Cluster for Naturalness and Plant-Based Industries Public business cluster, French Cluster, Food and Beverage Manufacturing | Other 3 Mar 2025 | | |
 Réseau Entreprendre Startup accelerator & VC | Réseau Entreprendre Startup accelerator & VC | Other 3 Apr 2025 | | |
 GROUPE M6 Media, Broadcast Media Production and Distribution | GROUPE M6 Media, Broadcast Media Production and Distribution | Other 28 Jun 2024 | | |
 CEEI Nice Côte d'Azur Government Administration | CEEI Nice Côte d'Azur Government Administration | Other 27 Feb 2024 | | |
 | Réseau SATT | Other 3 Nov 2023 | | |